RE:RE:CXR (for it to move up)select1011 wrote: I agree that sector sentiment can weigh on and lift SPs, but the sentiment problem in biotech isn't fundamentals based like oil or banking or resources. Its about rhetoric, shameful politics and misunderstanding. In addition to releasing good results, the company also has to be out there responding to rhetoric, politicians and those who don't understand. Show AND tell. Maybe the CEO could consider putting out a tweet saying "Concordia is astonished at the price gouging practices of some companies. Concordia doesn't rely on price jacks. Our books are open. We applaud efforts to investigate non- corporate citizen like practices." Probably too long for a tweet - but he'd probably get a dozen requests to be intervened within hours of getting that message out. What's wrong with that, if the story is true. If he can say it in Whister, he can say on CNBC and BNN and wherever.
I think you are over-estimating the power of the CEO to counteract perceived weaknesses in the global economy by making positive statements about CXR. Jeez man the world is practically in a recession! You don't see the CEOs of IBM, Apple, Shell, Pfizer etc pumping up their respective company on the media networks!